65,437 trials
Complicated Intra-abdominal Infection · Hosptial Acquired Pneumonia · Ventilator Associated Pneumonia
Primary: Percentage of Participants With Clinical Cure at Test of Cure (TOC) Visit: Intent-To-Treat (ITT) Analysis Set — 68.4; 65.7 Percentage of participants
Neurotrophic Keratopathy
Primary: Mean Change From Baseline in Corneal Fluorescein Staining — -0.6; -0.9 score on a scale
Total Shoulder Arthroplasty · Shoulder Osteoarthritis
Primary: Numerical Rating Score for Pain — 0.00; 0.00; 0.00; 0.00 score on a scale
Female Urogenital Diseases · Vaginal Atrophy · Postmenopausal Atrophic Vaginitis
Primary: Quantitative Change in Relative Abundance of Lactobacillus Among the Community Composition of Bacteria in the Vagina — 0.07; 0.09; 0.12; 0.04 Relative abundance
Diabetes Mellitus, Type 2
Primary: Area Under the Curve (AUC(0-16)) of Endogenous Glucose Production — 3436.8; 3139.3 mg*hr/dL — p=0.1628
Tobacco Use
Primary: Number of Participants Who Report Post-treatment Satisfaction — 15; 10 Participants
Heart Transplant
Primary: Survival — 76; 75 Participants — p=<0.0001
Breast Cancer
Primary: Change in Percent Expression of Ki67 Measured by Immunohistochemistry (IHC) — -3.6; -5.1; -4.2 Change in percentage expression of ki 67
Dementia
Primary: Number of Participants With Dementia With Medically Treated Falls — 24 Participants
Metastatic Castration-Resistant Prostate Cancer · Ovarian Cancer · Epithelial Ovarian Cancer
Primary: Number of Participants Experiencing SAEs and AESIs — 2; 0 Participants
Adenovirus Infection · BK Virus Infection · Cytomegalovirus Infections
Primary: Number of Participants Experiencing Clinically Significant Infections or Episodes of End-organ Disease — 3 Participants
Human Papilloma Virus · Oropharyngeal Squamous Cell Carcinoma
Primary: Disease Specific Survival (DSS) — 29; 15; 15 participants
Aortic Aneurysm · Thoracoabdominal Aneurysm · Aortic Dissection
Primary: Number of Total Postoperative Complications — 69 post-operative complications
Myocardial Infarction · Thrombosis · Platelet Dysfunction
Primary: Change in Maximal Platelet Aggregation in Response to Clopidogrel — 32.6; 50.8; 35.0 Percent Maximal Platelet Aggregation — p=<0.001
Osteoarthritis, Knee
Primary: Mean Difference in Quality Adjusted Life Years (QALY) — 0.74; 0.73 score on a scale — p=0.69